SCHEMBL14919100

SCHEMBL14919100

CC(C)(C)OC(=O)C1CC2(CCNC2)CCN1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21996242 0.93 MAPK1 (0.31) MAPK1
SCHEMBL31732068 0.80 HRH3 (0.33) MAPK1
SCHEMBL11002456 0.79 CTSC (0.34) MAPK1
SCHEMBL30335568 0.78 HRH3 (0.31) MAPK1
SCHEMBL29172772 0.74
SCHEMBL25340995 0.73 MAPK1 (0.34) MAPK1
SCHEMBL16555248 0.73 BACE1 (0.36)
SCHEMBL29172798 0.73
SCHEMBL30749401 0.72 BACE1 (0.41)
Hydrochloric Acid SCHEMBL31743747 0.72 MAPK1 (0.31) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773351-A2 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2014-09-10 EP disclosed
WO-2013066718-A2 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-05-10 WO disclosed